ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Options Flow

Live Options Flow

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P TSX Capped Composite...
40.36
0.17%
US Tech 100
20,911.20
0.90%
S&P 500
6,037.88
0.72%
US Dollar vs CAD
1.43147
-0.14%
Bitcoin
97,959.32
0.10%
Registration Strip Icon for smarter Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. Canada
  5. TSXV

  6. Appulse Corporation (APL) Share Price

Appulse Corporation

Appulse Corporation (APL)

Associate Global Partners Ltd
Alpha Pro Tech Ltd
0.21
0.00
(0.00%)
Closed February 05 3:00PM
Delayed by 15 minutes

Professional-Grade Tools, for Individual Investors.

Premium

Key stats and details

Current Price
0.21
Bid
0.205
Ask
0.23
Volume
-
0.00 Day's Range 0.00
0.165 52 Week Range 0.46
Market Cap
3.071M
Previous Close
0.21
Open
-
Last Trade
Last Trade Time
Financial Volume
-
VWAP
-
Average Volume (3m)
9,796
Shares Outstanding
14,622,000
Dividend Yield
-
PE Ratio
1.82
Earnings Per Share (EPS)
0.12
Revenue
10.37M
Net Profit
1.69M

About Appulse Corporation

Sector
Commercial Equip-whsl, Nec
Industry
Commercial Equip-whsl, Nec
Website
www.appulsecorp.net
Headquarters
Calgary, Alberta, Can
Founded
-
Appulse Corporation is listed in the Commercial Equip-whsl sector of the TSX Venture Exchange with ticker APL. The last closing price for Appulse was $0.21. Over the last year, Appulse shares have traded in a share price range of $ 0.165 to $ 0.46.

Appulse currently has 14,622,000 shares outstanding. The market capitalization of Appulse is $3.07 million. Appulse has a price to earnings ratio (PE ratio) of 1.82.

Ask ADVFN Intelligence (AI)

APL Latest News

More News

Appulse Corporation – Reporting results for the Nine Months ended September 30, 2022

CALGARY, Alberta, Nov. 18, 2022 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) today reported a net income of $201,000 ($.01per share) for the nine months ended September 30, 2022, with...

November 18 2022
GlobeNewswire Inc.

Appulse Corporation – Reporting results for the Six Months Ended June 30, 2022

CALGARY, Alberta, Aug. 26, 2022 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) (Listed on the TSX Venture Exchange – Symbol ‘APL’) today reported a net income of $79,000 for the six months...

August 26 2022
GlobeNewswire Inc.

Appulse Corporation – Reporting results for the First Quarter of 2022

CALGARY, Alberta, May 26, 2022 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) (Listed on the TSX Venture Exchange – Symbol ‘APL’) today reported a net income of $26,000 for the three months...

May 26 2022
GlobeNewswire Inc.

Appulse Corporation Reporting 2021 Results

CALGARY, March 25, 2022 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse” or “the Corporation”) (TSX-V:APL) today reported revenues of $9,233,000 for the year ended December 31, 2021, compared...

March 25 2022
GlobeNewswire Inc.

Reporting the Granting of Stock Options

CALGARY, Alberta, Jan. 26, 2022 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse” or the “Corporation”) (Listed on the TSX Venture Exchange – Symbol ‘APL’) today reported the granting of an...

January 26 2022
GlobeNewswire Inc.

Appulse Corporation - Reporting results for the Nine Months ended September 30, 2021

CALGARY, Alberta, Nov. 19, 2021 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) today reported a net income of $670,000 ($.05 per share) for the nine months ended September 30, 2021, with...

November 19 2021
GlobeNewswire Inc.

Appulse Corporation – Reporting Results for the Six Months Ended June 30, 2021

CALGARY, Alberta, Aug. 18, 2021 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) (Listed on the TSX Venture Exchange – Symbol ‘APL’) today reported a net income of $586,000 for the six...

August 18 2021
GlobeNewswire Inc.

Appulse Corporation: Reporting results for the First Quarter of 2021

CALGARY, Alberta, May 20, 2021 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) (Listed on the TSX Venture Exchange – Symbol ‘APL’) today reported a net income of $239,000 for the three...

May 20 2021
GlobeNewswire Inc.

Appulse Corporation: Reporting 2020 results

CALGARY, Alberta, April 15, 2021 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse” or “the Corporation”) today reported revenues of $10,461,000 for the year ended December 31, 2020, compared to...

April 15 2021
GlobeNewswire Inc.

Appulse Corporation: Reporting results for the Nine Months ended September 30, 2020

CALGARY, Alberta, Nov. 18, 2020 (GLOBE NEWSWIRE) -- Appulse Corporation (“Appulse”) today reported a net income of $758,000 ($.05 per share) for the nine months ended September 30, 2020 with...

November 18 2020
GlobeNewswire Inc.
PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.0052.439024390240.2050.210.20510000.21CS
4000.210.220.2058570.21182953CS
12000.210.220.20597960.21514592CS
26-0.12-36.36363636360.330.3650.165113370.2421704CS
52-0.16-43.24324324320.370.460.165104110.30872879CS
156-0.11-34.3750.320.550.16557750.32996478CS
2600.0531.250.160.550.09563750.32571322CS

APL - Frequently Asked Questions (FAQ)

What is the current Appulse share price?
The current share price of Appulse is $ 0.21
How many Appulse shares are in issue?
Appulse has 14,622,000 shares in issue
What is the market cap of Appulse?
The market capitalisation of Appulse is CAD 3.07M
What is the 1 year trading range for Appulse share price?
Appulse has traded in the range of $ 0.165 to $ 0.46 during the past year
What is the PE ratio of Appulse?
The price to earnings ratio of Appulse is 1.82
What is the cash to sales ratio of Appulse?
The cash to sales ratio of Appulse is 0.3
What is the reporting currency for Appulse?
Appulse reports financial results in CAD
What is the latest annual turnover for Appulse?
The latest annual turnover of Appulse is CAD 10.37M
What is the latest annual profit for Appulse?
The latest annual profit of Appulse is CAD 1.69M
What is the registered address of Appulse?
The registered address for Appulse is SUITE 603, 734 - 7 AVENUE S.W, CALGARY, ALBERTA, T2P 3P8
What is the Appulse website address?
The website address for Appulse is www.appulsecorp.net
Which industry sector does Appulse operate in?
Appulse operates in the COMMERCIAL EQUIP-WHSL, NEC sector

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
ROCKEros Resources Corp
 0.06
(300.00%)
644.88k
NICKNickelex Resource Corporation
$ 0.01
(100.00%)
161k
TVITVI Pacific Inc
$ 0.01
(100.00%)
150k
PORPortofino Resources Inc
$ 0.01
(100.00%)
240k
FUNDKatipult Technology Corp
$ 0.01
(100.00%)
20k
DMDataMetrex AI Limited
$ 0.005
(-50.00%)
2.18M
NZPChatham Rock Phosphate Limited
$ 0.055
(-35.29%)
9k
CCDCascadero Copper Corporation
$ 0.01
(-33.33%)
4k
HBKHighbank Resources Ltd
$ 0.01
(-33.33%)
35k
SCLTSearchlight Resources Inc
$ 0.01
(-33.33%)
242k
WGOWhite Gold Corp
$ 0.20
(17.65%)
11.26M
GPUSAlset AI Ventures Inc
$ 0.115
(15.00%)
4.47M
OMIOrosur Mining Inc
$ 0.19
(65.22%)
4.45M
BRCBlackrock Silver Corp
$ 0.355
(9.23%)
2.48M
XBOTRealbotix Corp
$ 0.48
(-4.00%)
2.41M

Discussion

View Full Feed
muee88 muee88 5 minutes ago
Also, the Proposed 24-25 HC drug list is alphabetical, but Murcidencel is listed under the Bs because “Brain Cancer Vaccine” is crossed out and replaced with Murcidencel.
NWBO
TurboMountain96 TurboMountain96 5 minutes ago
Frankly, we are the original MEGA, Make Elite Great Again. We had that slogan long before Trump entered politics or plagiarized from Ronald Reagan, who originally started Make America Great Again. So to that end, maybe to support the stockholders, our MEGA, we’re going to build a wall of needle move
ELTP
RichieBoy RichieBoy 6 minutes ago
Only stating the patently obvious here...

When AFFU's dilution stops, the share price contraction stops. Just that simple. I get a strong sense the company is intentionally stalling for that reason. Mike Balkin and AFFU's other board member(s?) don't want to waste material event comp
AFFU
OnTrack444 OnTrack444 7 minutes ago

Is this your newest made pump account with a 122 followers on X?   😂   Total comedy 🎭 

How much do they pay you to pump bloated pigs because you cer
HMBL
muee88 muee88 10 minutes ago
Unfortunately, I don’t know how to upload a screenshot to this antiquated website —it shouldn’t be this difficult. I can assure you I’m not lying. Also, an email can be faked too so I’m not really sure what a screenshot would tell you.

However, here’s essentially the full text of the
NWBO
123tom 123tom 13 minutes ago
Steve, what you're saying about AVXL price movement not holding the support levels you'd expect... that's something I've watched AVXL do for 14 years. It's what I call the "bleeding down game". I always expect to see lower lows than we ought to see. Even in bullish upwave patterns.... the seller
AVXL
muee88 muee88 16 minutes ago
You need to click the tap entitled “Proposed 24-25 HC drugs.” On my phone, the tab I’m talking about is shown across the top of the website.
NWBO
skitahoe skitahoe 18 minutes ago
When I use your link I get a list of their hospitals, not drugs, am I doing something wrong, or is there a problem with the link.

Thanks,

Gary
NWBO
roadkilll roadkilll 23 minutes ago
Why central banks’ hunger for gold shows ‘no sign of being quelled’ this year
Published: Feb. 5, 2025

Central banks, as well as exchange-traded-fund investors, are likely to drive gold demand this year, with economic uncertainty supporting gold’s role as a risk hedge, the Worl
IAG
demonsmith demonsmith 23 minutes ago
There working on it noting going to happen intell after shareholder metting
TWOH
roadkilll roadkilll 27 minutes ago
Tesla hasn't paid taxes in 3 years
200 P/E
5.5 PEG
$7500 taxpayer from taxpayers to anyone buying a new Tesla
$4000 taxpayer funded payment anyone buying a used Tesla to keep the flow going
30% taxpayer funding to anyone that instals a home battery unit ($3000 if y
TSLA
bluebird50 bluebird50 28 minutes ago
I had a 50 share marker on this and sold it first thing Monday morning.... 

Not feeling good here.... 
pharmas have huge upswings with steady declines!!!  

Time it ladies and gentlemen! 
TNXP
Seminole Red Seminole Red 28 minutes ago
LOLOL
DJPele DJPele 30 minutes ago
Muee, apologies for being persistent, but can you provide a screenshot of the email from the MHRA?
NWBO
muee88 muee88 37 minutes ago
I asked ChatGPT what it meant:

Me: Does Murcidencel being on this list imply that this drug is going to be approved for a marketing authorization?

ChatGPT:

No, the inclusion of Mircidencel on the NHS Proposed 24-25 High-Cost Drugs List does not necessaril
NWBO
muee88 muee88 51 minutes ago
What does Murcidencel being included on this list of “High cost drugs - proposed list for 2024/25” mean?

https://www.england.nhs.uk/wp-content/uploads/2023/12/23-25NHSPS-amendment-consultation-annex.xlsx
NWBO
Werbe Werbe 56 minutes ago
Let's get a pr about future intentions, how we make this a $50 m cap company.  I think we can achieve that at least.
ATWT
Seminole Red Seminole Red 57 minutes ago
100 feet in difference is only 33 yards, thats pretty close for two vehicles in the air
DocLee DocLee 57 minutes ago
HI, DH. Sorry, I don't know whether anybody has contacted either NWBO or the MHRA but you could do it yourself. That would be a much easier option than trawling through tens (or even hundreds) of thousands of messages on this board that have been posted since the MHRA started its assessments. Bes
NWBO
chereb19 chereb19 59 minutes ago
The primary objective of this phase I trial is to assess the safety and feasibility of the treatment.
Notably, one patient experienced an exceptional 80% reduction in tumor size during this trial so far. Such a significant response is uncommon in phase I trials, which are primarily designed t
RDGL
trader53 trader53 1 hour ago
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS - Company Update with CEO 2/13/2025
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175756306

DPLS 0.0006 - ALERTING STRONG BUY!
https://investorshub.advfn.com/boards/read_msg.aspx?mess
DPLS MFI
Seminole Red Seminole Red 1 hour ago
cant wait to see what Bondi does her first day
trader53 trader53 1 hour ago
DPLS 0.00055 - ALERTING STRONG BUY!


DPLS - Company Update with CEO 2/13/2025
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175756306

DPLS 0.0006 - ALERTING STRONG BUY!
https://investorshub.advfn.com/boards/read_msg.aspx?mess
DPLS MFI

Your Recent History

TSXV
APL
Appulse
BIT
P1ID41
BNP Paribas Issuance
BIT
K72076
Banca Akros
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Canada
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2025 ADVFN PLC - All Rights Reserved

Go Ad-Free

Subscribe to Ad free and enjoy an ad-free experience

No Ads

Try Now

Keep the Ads